Posted by Michael Wonder on 07 Aug 2018
CMS empowers patients with more choices and takes action to lower drug prices
7 August 2018 - Agency is providing flexibility through private sector tools to negotiate lower prescription drug prices on behalf of beneficiaries.
Today, the Centers for Medicare & Medicaid Services delivered on President Trump’s promise to negotiate better deals for Medicare patients and create competition between drugs used to treat the same conditions, with more than half of the savings required to be passed on directly to patients.
This action gives Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs and is an important step within the Administration’s larger agenda to provide patients with more choices when picking a Medicare Advantage plan that best meets their needs.
